Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus (Q46901740)
Jump to navigation
Jump to search
scientific article published in February 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus |
scientific article published in February 2006 |
Statements
1 reference
Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus (English)
1 reference
Kristian F Hanssen
1 reference
Dag Sigurd Fosmark
1 reference
Peter A Torjesen
1 reference
Bente K Kilhovd
1 reference
Tore J Berg
1 reference
Leiv Sandvik
1 reference
Carl-David Agardh
1 reference
Elisabet Agardh
1 reference
1 February 2006
1 reference
1 reference
55
1 reference
232-236
1 reference
2
1 reference
Identifiers
1 reference
1 reference